Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
US Department of Justice
Express Scripts
QuintilesIMS
Johnson and Johnson
Fuji
Accenture
Colorcon
Julphar

Generated: May 26, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,780,881

« Back to Dashboard

Which drugs does patent 6,780,881 protect, and when does it expire?

Patent 6,780,881 protects PROTONIX IV and is included in one NDA.

Protection for PROTONIX IV has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

This patent has fifty-five patent family members in forty countries.
Summary for Patent: 6,780,881
Title: Freeze-dried pantoprazole preparation and pantoprazole injection
Abstract:Lyophilized pantoprazole preparations which are obtainable by freeze-drying of an aqueous solution of pantoprazole, ethylenediamine tetraacetic acid and/or a suitable salt thereof, and sodium hydroxide and/or sodium carbonate are disclosed. The preparations have advantageous properties when reconstituted for injection.
Inventor(s): Linder; Rudolf (Constance, DE), Dietrich; Rango (Constance, DE)
Assignee: Altana Pharma AG (Constance, DE)
Application Number:10/195,062
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 6,780,881
Patent Claim Types:
see list of patent claims
Formulation; Compound; Process; Device;

Drugs Protected by US Patent 6,780,881

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Wyeth Pharms Inc PROTONIX IV pantoprazole sodium INJECTABLE;IV (INFUSION) 020988-001 Mar 22, 2001 AP RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 6,780,881

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
00125569Nov 22, 2000

Non-Orange Book US Patents Family Members for Patent 6,780,881

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
7,351,723 Freeze-dried pantoprazole preparation and pantoprazole injection ➤ Sign Up
8,754,108 Freeze-dried pantoprazole preparation and pantoprazole injection ➤ Sign Up
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
US Army
Accenture
Healthtrust
Covington
Cantor Fitzgerald
Cipla
Boehringer Ingelheim
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.